z-logo
open-access-imgOpen Access
Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
Author(s) -
Ahmed Alzamzamy,
Hany M. ElSayed,
Mona Abd El-Raouf,
Hanan Eltoukhy,
Tarek Megahed,
Ashraf Aboubakr
Publication year - 2021
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v13.i6.600
Subject(s) - medicine , hepatocellular carcinoma , vascular endothelial growth factor , hepatitis c virus , carcinoma , virus , pathology , gastroenterology , virology , vegf receptors
Hepatocellular carcinoma (HCC) accounts for 8.2% of all cancer-related deaths worldwide. Being a vascular tumor, vascular endothelial growth factor (VEGF) plays a vital role in HCC pathogenesis, growth, and spread.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here